Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression - GlobeNewswire

Submitted by Anonymous (not verified) on Mon, 02/22/2021 - 13:00

Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression  GlobeNewswire